癌症研究
错义突变
生物
体细胞
抗药性
基因
突变
细胞培养
奥沙利铂
原发性肿瘤
药品
癌症
癌症的体细胞进化
基因组不稳定性
种系突变
细胞
干细胞
医学
生殖系
癌变
基因突变
作者
Jiahui Xi,Mingzhen Bai,Ruyang Zhong,Chongfei Huang,Ruoshui An,Long Gao,Haidong Ma,Liang Tian,Jinyu Zhao,Ningzu Jiang,Xiang He,L L Wang,Zihe Dong,Ping Yue,Yanyan Lin,Zhongtian Bai,Wenbo Meng
出处
期刊:Human Cell
[Springer Science+Business Media]
日期:2026-03-31
卷期号:39 (4)
标识
DOI:10.1007/s13577-026-01369-1
摘要
Distal cholangiocarcinoma (dCCA) is a malignant tumor characterized by a challenging diagnosis, high invasiveness, and extremely poor prognosis. Research on dCCA is limited by the scarcity of reliable patient-derived preclinical tumor models. This study established a novel human distal cholangiocarcinoma cell line, CBC3T-3, and systematically characterized its biological properties, genomic features, and potential for clinical application. This cell line was extracted from postoperative distal cholangiocarcinoma tumor from a 54-year-old male patient. It was stably passaged (> 50 generations) through primary culture and condition optimization, preserving the same pathology as that of the primary tumor. Whole-exome sequencing (WES) confirmed somatic mutations, tumor mutation burden, single-sample clonal structure, driver genes, and drug resistance genes in CBC3T-3 cells, revealing their genomic characteristics. Functional assays demonstrated that CBC3T-3 cells exhibit strong capabilities for proliferation, migration, and invasion in vitro. In a subcutaneous xenograft model in immunodeficient mice, palpable tumor nodules developed within 4 weeks, reflecting the clinical characteristics of rapidly progressive disease. Drug sensitivity analysis revealed that, compared with TFK-1 cells, CBC3T-3 cells presented significantly greater responses to paclitaxel, gemcitabine, and oxaliplatin but relatively poor responses to 5-FU and cisplatin. The integration of drug resistance gene findings from WES suggests that TP53 missense mutations may mediate primary resistance to cisplatin. The establishment of the CBC3T-3 cell line enhances the research toolkit for dCCA. Its genomic characteristics and functional plasticity provide a reliable preclinical tumor model for developing precision therapies and investigating drug resistance mechanisms.
科研通智能强力驱动
Strongly Powered by AbleSci AI